It is currently a subsidiary of Meiji Holdings[1] and a Japanese leader in the area of infectious disease with 18% market share.

It markets treatments for depression, obsessive-compulsive disorder, vaccines and allergy drugs.

Meiji Pharma is doing research in generic anticancer drugs and biosimilars with partner organisations.

You can help Wikipedia by expanding it.This food and/or confectionery corporation or company-related article is a stub.

You can help Wikipedia by expanding it.This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.